Cargando…
Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme‐linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity
AIM/INTRODUCTION: Autoantibodies to the 65 kDa isoform of glutamic acid decarboxylase (GADA) are a valuable diagnostic and predictive marker for type 1 diabetes. Recently, it has been reported that a significant proportion of sera in the commercial RSR radioimmunoassay (RIA) that have tested positiv...
Autores principales: | Kawasaki, Eiji, Okada, Akira, Uchida, Aira, Fukuyama, Takahiro, Sagara, Yoko, Nakano, Yuko, Tamai, Hidekazu, Tojikubo, Masayuki, Koga, Nobuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626941/ https://www.ncbi.nlm.nih.gov/pubmed/30582775 http://dx.doi.org/10.1111/jdi.12996 |
Ejemplares similares
-
Characterization of patients with diabetes who were incidentally found to be glutamic acid decarboxylase autoantibody‐positive by bridging‐type enzyme‐linked immunosorbent assay
por: Kawasaki, Eiji, et al.
Publicado: (2020) -
Comparison of Measurements of Autoantibodies to Glutamic Acid Decarboxylase and Islet Antigen-2 in Whole Blood Eluates from Dried Blood Spots Using the RSR-Enzyme Linked Immunosorbent Assay Kits and In-House Radioimmunoassays
por: Persson, Anders, et al.
Publicado: (2010) -
Statin‐induced autoimmune hepatitis in patients with type 1 diabetes: A report of two cases and literature review
por: Kawasaki, Eiji, et al.
Publicado: (2020) -
Efficacy of omarigliptin, once-weekly dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes
por: Kawasaki, Eiji, et al.
Publicado: (2021) -
Development of type 1 diabetes in a patient treated with anti‐interleukin‐6 receptor antibody for rheumatoid arthritis
por: Kawasaki, Eiji, et al.
Publicado: (2021)